Clinical Trial Update: Flat and Circadian Insulin Infusion Rates in Continuous Subcutaneous Insulin Infusion [NA]

View source ↗

Summary

Completed clinical trial on flat and circadian insulin infusion rates in continuous subcutaneous insulin infusion for Type 1 Diabetes; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Imperial College London | Conditions: Type 1 Diabetes | NA | Status: COMPLETED | Results posted: 2020-03-31